Marshall Wace North America’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,578
Closed -$753K 1846
2021
Q1
$753K Buy
+1,578
New +$753K ﹤0.01% 1085